Publications by authors named "Michael Citron"

Claim this Profile
T
Toll-like receptor 7/8 agonist stimulation rapidly skews the antibody repertoire of B cells in non-human primates.
Shiyu Wang, Michael Citron, Lihua Luo, I-Ming Wang, Xiao Liu

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of RSV Fusion Protein Adsorbed to Non-Pathogenic Spores: Implications for Mucosal Vaccine Delivery in Nonclinical Animal Models.
Jianying Xiao, Hao Wang, Cheryl Callahan, Gregory O'Donnell, Silveria Rodriguez, Michael P Citron

Biomedicines· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a non-nucleoside inhibitor of the RSV RNA-dependent RNA polymerase in translatable animals models.
Michael P Citron, Xiaowei Zang, Andrew Leithead, Shi Meng, William A Rose Ii

J Infect· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates.
Chengwei Wu, Izzat T Raheem, Debbie D Nahas, Michael Citron, Peter S Kim

Proc Natl Acad Sci U S A· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults.
Jesse Nussbaum, Xin Cao, Radha A Railkar, Jeffrey R Sachs, Daniel S Spellman, Michael P Citron

Vaccine· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Rotavirus Reverse Genetics Platform Supports Flexible Insertion of Exogenous Genes and Enables Rapid Development of a High-Throughput Neutralization Assay.
Jiajie Wei, Scott Radcliffe, Amanda Pirrone, Meiqing Lu, Yuan Li, Michael Citron

Viruses· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera.
Amy S Espeseth, Maoli Yuan, Michael Citron, Lucia Reiserova, Gavin Morrow

EBioMedicine· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates.
Jessica A Flynn, Teresa Weber, Pedro J Cejas, Kara S Cox, Sinoeun Touch, Michael P Citron

Vaccine· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates.
Tomer Zohar, Jeff C Hsiao, Nickita Mehta, Jishnu Das, Anush Devadhasan, Michael P Citron

Cell Host Microbe· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs.
Michael P Citron, Jessica McAnulty, Cheryl Callahan, Walter Knapp, Jane Fontenot

Pathogens· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine Hyporesponse Induced by Individual Antibiotic Treatment in Mice and Non-Human Primates Is Diminished upon Recovery of the Gut Microbiome.
Gokul Swaminathan, Michael Citron, Jianying Xiao, James E Norton, Abigail L Reens

Vaccines (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates.
Morgan A Monslow, Sayda Elbashir, Nicole L Sullivan, David S Thiriot, Patrick Ahl, Michael Citron

Vaccine· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection.
Amy S Espeseth, Pedro J Cejas, Michael P Citron, Dai Wang, Daniel J DiStefano

NPJ Vaccines· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein.
Aimin Tang, Zhifeng Chen, Kara S Cox, Hua-Poo Su, Cheryl Callahan, Michael P Citron

Nat Commun· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates.
Michael P Citron, Manishkumar Patel, Mona Purcell, Shu-An Lin, Daniel J Rubins

Vaccine· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys.
Hualin Li, Cheryl Callahan, Michael Citron, Zhiyun Wen, Sinoeun Touch

PLoS One· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Stability of Parainfluenza Virus 5-Vectored Human Respiratory Syncytial Virus Vaccine Candidates after and Passage.
Shannon I Phan, Carolyn M Adam, Zhenhai Chen, Michael Citron, Xiaoping Liang

J Virol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
Dai Wang, Shannon Phan, Daniel J DiStefano, Michael P Citron, Cheryl L Callahan

J Virol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies.
Sannula Kesavardhana, Raksha Das, Michael Citron, Rohini Datta, Linda Ecto

J Biol Chem· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype.
V Vamsee Aditya Mallajosyula, Michael Citron, Francesca Ferrara, Nigel J Temperton, Xiaoping Liang

Front Immunol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection.
Vamsee V A Mallajosyula, Michael Citron, Francesca Ferrara, Xianghan Lu, Cheryl Callahan

Proc Natl Acad Sci U S A· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo characterization of designed immunogens derived from the CD-helix of the stem of influenza hemagglutinin.
V Vamsee Aditya Mallajosyula, Michael Citron, Xianghan Lu, Jan Ter Meulen, Raghavan Varadarajan

Proteins· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of Escherichia coli-expressed stalk domain immunogens of H1N1 hemagglutinin that protect mice from lethal challenge.
Gayathri Bommakanti, Xianghan Lu, Michael P Citron, Tariq Ahmad Najar, Gwendolyn J Heidecker

J Virol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule mimetics of an HIV-1 gp41 fusion intermediate as vaccine leads.
Michael J Caulfield, Vadim Y Dudkin, Elizabeth A Ottinger, Krista L Getty, Paul D Zuck, Michael Citron

J Biol Chem· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.
Gayathri Bommakanti, Michael P Citron, Robert W Hepler, Cheryl Callahan, Gwendolyn J Heidecker

Proc Natl Acad Sci U S A· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis